Het FOCUS-project: OpbrengstGericht Werken op basis van prestatie-feedback

In het FOCUS-project is een tweeejarige training ‘OpbrengstGericht Werken’ voor complete basisschoolteams ontwikkeld. Het is de bedoeling dat basisscholen door de training allereerst leren om de mogelijkheden van het leerlingvolgsysteem dat ze bezitten beter te benutten. De praktijk leert namelijk dat veel scholen maar een klein deel van die mogelijkheden gebruiken. Dat is zonde, omdat onderzoek duidelijk heeft aangetoond dat het goed benutten van feedback waarvan je over de kwaliteit van je eigen handelen leert sterk prestatieverbeterende effecten kan hebben. De training gaat echter verder. Scholen leren vervolgens namelijk om op basis van het inzicht in hun prestaties doelen te stellen die voldoen aan de principes van de goal setting theorie (uitdagende, haalbare en evalueerbare doelen). Daarnaast bieden we rekendidactische informatie aan evenals informatie over de kenmerken van rekensterke scholen, die scholen kunnen gebruiken om hun onderwijs zo aan te passen dat de kans op het behalen van de gestelde doelen groot wordt. In het artikel worden de ontwikkeling en inhoud van de training, evenals de ervaringen met scholen die de training volgden, nader beschreven

Health Care Fraud and Abuse Laws Affecting Medicare and Medicaid: An Overview

This report provides an overview of some of the more commonly used federal statutes used to fight health care fraud and abuse and discusses some of the changes made to these statutes by the Patient Protection and Affordable Care Act (ACA)

Premium Tax Credits and Federal Health Insurance Exchanges: Questions and Answers

Legal challenges that may have a substantial impact on the implementation and operation of the Patient Protection and Affordable Care Act (ACA) concern whether premium tax credits are available for millions of individuals participating in federally administered health insurance exchanges. The Supreme Court has decided to weigh in on this issue in King v. Burwell. This report provides background on provisions of ACA relevant to this issue. It then answers questions concerning the legal challenges and potential implications of the Court's decision in King

Accounting for quality improvement during the conduct of embedded pragmatic clinical trials within healthcare systems: NIH Collaboratory case studies

Embedded pragmatic clinical trials (ePCTs) and quality improvement (QI) activities often occur simultaneously within healthcare systems (HCSs). Embedded PCTs within HCSs are conducted to test interventions and provide evidence that may impact public health, health system operations, and quality of care. They are larger and more broadly generalizable than QI initiatives, and may generate what is considered high-quality evidence for potential use in care and clinical practice guidelines. QI initiatives often co-occur with ePCTs and address the same high-impact health questions, and this co-occurrence may dilute or confound the ability to detect change as a result of the ePCT intervention. During the design, pilot, and conduct phases of the large-scale NIH Collaboratory Demonstration ePCTs, many QI initiatives occurred at the same time within the HCSs. Although the challenges varied across the projects, some common, generalizable strategies and solutions emerged, and we share these as case studies. KEY LESSONS: Study teams often need to monitor, adapt, and respond to QI during design and the course of the trial. Routine collaboration between ePCT researchers and health systems stakeholders throughout the trial can help ensure research and QI are optimally aligned to support high-quality patient-centered care

115th Congress

This report focuses on the U.S. Food and Drug Administration (FDA) as a key player in federal efforts to curb the opioid epidemic. It provides an overview of FDA's role in approving new prescription drugs, including challenges of approval and regulation of opioid products; addresses FDA's multifaceted approach in responding, including recent agency action; and concludes with a discussion of selected opioid-related legislation in the 115th Congress